KNOXVILLE, Tenn.--(BUSINESS WIRE)--EDP Biotech Corporation, an in-vitro cancer diagnostics development company, today announced that its abstract “CA 11-19: A Tumor Marker for the Diagnosis of Colorectal Cancer” has been accepted for presentation at the 2014 ASCO (American Society of Clinical Oncology) meeting in Chicago being held on May 30 – June 3, 2014.
Help employers find you! Check out all the jobs and post your resume.